Copy Link Print Information

Emfizatamab

(別名: GNC-038)
カスタマーレビュー

Based on 1 Customer Validation

Emfizatamab (GNC-038) is a monoclonal antibody against CD19/CD3E/TNFRSF9/PD-L1. Emfizatamab exhibits antitumor activity, being capable of activating CD3 and 4-1BB signals on T cells, as well as targeting the high expression of CD19 or PD-L1 on tumor cells. Emfizatamab functions as a CD19-specific T cell engager by mediating direct antitumor activity. Emfizatamab can also overcome the inhibition of T cells by PD-L1. Emfizatamab can be used in the research of tumors such as R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度: 95.495%
  • CAS 番号: 2559704-23-1
  • 分子量:303.229 kDa
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Emfizatamab Chemical Structure
    Emfizatamab 構造式
CAS 番号: 2559704-23-1
容量
価格（税別）
在庫状況
数量
Amount: USD 0.00
Please select quantity
or
or

* アイテムを追加する前、数量をご選択ください

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Emfizatamab おすすめ製品:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
最寄りの代理店をお探しください Your local distributor: Hycultec GmbHHycultec
  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

TNF Receptor アイソフォーム固有の製品をすべて表示

More

Interleukin Related アイソフォーム固有の製品をすべて表示

More
Keywords
100 mg

お問い合わせ 在庫あり

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress ログイン
Register
Sign in to MedChemExpress
新規会員登録

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.

  • 1/16

    Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.

  • 1/16

    Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.

  • 1/16

    Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.

  • Emfizatamab Chemical Structure
    1/16
  • Emfizatamab
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.
  • Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.
  • Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.
  • Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.
  • (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)